Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year Wave Life plans a 2026 NDA filing for WVE-N531 after positive Phase 2 data in Duchenne ...
Then, the University of MarketBeat D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst? ([content-module:CompanyOverview, NYSE:QBTS) March has been a big month of research developments for D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback